Talis Biomedical Corporation
TLIS · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $77 | $130 | $233 | $138 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $3 | $3 | $50 |
| Total Curr. Assets | $78 | $133 | $236 | $189 |
| Property Plant & Equip (Net) | $15 | $34 | $23 | $10 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2 | $2 | $1 | $0 |
| Tax Assets | $4 | $7 | $0 | $0 |
| Other NC Assets | $2 | $2 | $6 | $0 |
| Total NC Assets | $21 | $36 | $30 | $10 |
| Other Assets | -$4 | $0 | $0 | $0 |
| Total Assets | $95 | $169 | $266 | $198 |
| Liabilities | – | – | – | – |
| Payables | $1 | $4 | $5 | $5 |
| Short-Term Debt | $3 | $4 | $2 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $12 | $10 |
| Other Curr. Liab. | $5 | $5 | -$0 | $0 |
| Total Curr. Liab. | $9 | $13 | $19 | $16 |
| LT Debt | $17 | $30 | $13 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $291 |
| Total NC Liab. | $17 | $30 | $13 | $291 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $20 | $34 | $14 | $1 |
| Total Liabilities | $26 | $43 | $32 | $307 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$540 | -$478 | -$365 | -$173 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $609 | $605 | $599 | -$227 |
| Total Equity | $69 | $127 | $234 | -$109 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $95 | $169 | $266 | $198 |
| Net Debt | -$57 | -$97 | -$217 | -$137 |